Quote:Filing date Aronow Capital, LLC
August 2024 9,304,443 beneficially owned
December 2025 8,339,543 beneficially owned
Aronow Capital was listed in the 2024 prospectus.
In his LinkedIn page from two months ago he created a post titled Leronlimab Delays for Metastatic Triple Negative Breast Cancer Patients Harmful.
He was already arguing publicly that the FDA should move faster, particularly for women with metastatic triple-negative breast cancer. Disclosed that he was a CytoDyn investor.
The link is essentially a paid PR, yes, but I wouldn't jump to the conclusion that he's a pump and dumper at all. He could be one of us, or perhaps one of the Reddit guys.